Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Chiral Indolinone. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Efficient asymmetric synthesis of chiral indolinone spiro compounds using cinchona alkaloid catalysts for high-purity pharmaceutical intermediates.
Novel method for chiral 3-fluoro-2-indolone derivatives via Ellman imine addition. High yield, mild conditions, scalable for API intermediates.
Patent CN117946130A reveals a novel cinchona-catalyzed route for chiral spiro indolinone derivatives, offering significant cost reduction and supply chain reliability for anti-tumor drug manufacturing.
Patent CN102584800A details an asymmetric synthesis of chiral indolinone-angelica lactone frameworks using cinchona alkaloid catalysis, offering high enantioselectivity for pharmaceutical intermediates.
Patent CN102924360A reveals efficient asymmetric hydrogenation for chiral indolinones. Discover cost-effective manufacturing and supply chain advantages for pharmaceutical intermediates.
Patent CN113735756A details a high-yield Rh-catalyzed method for chiral 3,3-disubstituted isoindolinones, offering significant cost reduction and supply chain reliability for pharmaceutical intermediates.
Patent CN113735756A details a novel Rh-catalyzed C-H activation method for chiral 3,3-disubstituted isoindolinones, offering high enantioselectivity and streamlined manufacturing for pharmaceutical intermediates.
Patent CN113735756A details a high-yield Rh-catalyzed method for chiral 3,3-disubstituted isoindolinones, offering significant cost reduction and supply chain reliability for pharmaceutical intermediates.
Patent CN113980028A reveals a mild organocatalytic route for chiral spiro indolones. Discover cost-effective manufacturing and high stereoselectivity for API intermediates.
Patent CN113735756B reveals high-yield rhodium catalysis for chiral isoindolinones. Offers cost reduction and supply chain reliability for pharmaceutical intermediate manufacturing.
Discover a novel method for preparing chiral spiro indolone compounds using cinchona alkaloid catalysts. High yield, mild conditions, and scalable pharma intermediate production.
Patent CN113735756A details a novel Rh-catalyzed [4+1] cyclization for high-purity chiral isoindolinones, offering significant cost reduction in API manufacturing.
Patent CN113735756A details a mild Rh-catalyzed method for chiral 3,3-disubstituted isoindolinones, offering high enantioselectivity and cost-effective manufacturing solutions.
Patent CN113735756A details a novel Rh-catalyzed method for chiral 3,3-disubstituted isoindolinones, offering high enantioselectivity and mild conditions for pharmaceutical manufacturing.
Patent CN113735756A details a high-yield Rh-catalyzed method for chiral 3,3-disubstituted isoindolinones, offering cost-effective pharma intermediate manufacturing.
Patent CN113735756B enables high-yield enantioselective isoindolinone production under mild conditions enhancing supply chain reliability for pharmaceutical intermediates
This patent discloses a novel rhodium-catalyzed method achieving high-yield enantioselective synthesis of chiral isoindolinones with significant cost reduction potential and enhanced supply chain reliability for pharmaceutical manufacturing.
Patent CN113735756B enables efficient chiral isoindolinone synthesis under mild conditions with up to 95% ee, delivering substantial cost savings and enhanced supply chain reliability for pharmaceutical manufacturers.
Patent CN113735756A enables high-yield enantioselective synthesis under mild conditions, enhancing supply chain reliability and reducing pharmaceutical manufacturing costs.
Solve multi-step synthesis challenges with rhodium-catalyzed asymmetric [4+1] cyclization. 91% yield, 95% ee, and mild conditions for stable API intermediates. Contact for CDMO solutions.